Allergic rhinitis--current pharmacotherapy.
The use of pharmacotherapy for allergic rhinitis remains a central strategy in the integrated treatment of the patient. The most appropriate medical therapy depends upon the nature of specific rhinitis symptoms, patient tolerance to and preference for certain classes of medications, and response to treatment. Through an appreciation of these various physiological mechanisms, the physician can select the treatment option or options that will be most likely to effectively manage symptoms.
Krouse
John H
JH
Rhinology and Allergy, Department of Otolaryngology, Wayne State University, 540 E. Canfield, 5E-UHC, Detroit, MI 48201, USA. jkrouse@med.wayne.edu <jkrouse@med.wayne.edu>
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D004358:Drug Therapy / Q000379:methods*; D005100:Expectorants / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007073:Immunoglobulin E / Q000187:drug effects; D020024:Leukotriene Antagonists / Q000627:therapeutic use; D014663:Nasal Decongestants / Q000627:therapeutic use; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D018680:Cholinergic Antagonists; D005100:Expectorants; D006634:Histamine H1 Antagonists; D020024:Leukotriene Antagonists; D014663:Nasal Decongestants; D007073:Immunoglobulin E